BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16288205)

  • 1. Gene expression profiling of breast cell lines identifies potential new basal markers.
    Charafe-Jauffret E; Ginestier C; Monville F; Finetti P; Adélaïde J; Cervera N; Fekairi S; Xerri L; Jacquemier J; Birnbaum D; Bertucci F
    Oncogene; 2006 Apr; 25(15):2273-84. PubMed ID: 16288205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
    Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
    Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stratification from analysis of micro-array data of micro-dissected specimens.
    Alexe G; Dalgin GS; Scanfeld D; Tamayo P; Mesirov JP; Ganesan S; Delisi C; Bhanot G
    Genome Inform; 2007; 18():130-40. PubMed ID: 18546481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated profiling of basal and luminal breast cancers.
    Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
    Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
    Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
    Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
    Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
    Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.
    Finetti P; Cervera N; Charafe-Jauffret E; Chabannon C; Charpin C; Chaffanet M; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Cancer Res; 2008 Feb; 68(3):767-76. PubMed ID: 18245477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
    Fadare O; Tavassoli FA
    Adv Anat Pathol; 2007 Sep; 14(5):358-73. PubMed ID: 17717437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
    Weigelt B; Kreike B; Reis-Filho JS
    Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
    Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
    Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis in SV40-immortalized human breast luminal epithelial cells with stem cell characteristics using a cDNA microarray.
    Park JS; Noh DY; Kim SH; Kim SH; Kong G; Chang CC; Lee YS; Trosko JE; Kang KS
    Int J Oncol; 2004 Jun; 24(6):1545-58. PubMed ID: 15138599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
    Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
    Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P
    Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of a customized multiple signature microarray for breast cancer.
    Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
    Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
    Vincent-Salomon A; Lucchesi C; Gruel N; Raynal V; Pierron G; Goudefroye R; Reyal F; Radvanyi F; Salmon R; Thiery JP; Sastre-Garau X; Sigal-Zafrani B; Fourquet A; Delattre O;
    Clin Cancer Res; 2008 Apr; 14(7):1956-65. PubMed ID: 18381933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.